Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
12,657,935
-
Number of holders
-
1
-
Total 13F shares, excl. options
-
25,315
-
Shares change
-
+25,315
-
Total reported value, excl. options
-
$40,504
-
Value change
-
+$40,504
-
Number of buys
-
1
-
Price
-
$1.60
Significant Holders of OnKure Therapeutics, Inc. - Common Stock, par value $0.0001 per share (RPHM) as of Q4 2023
1 filings reported holding RPHM - OnKure Therapeutics, Inc. - Common Stock, par value $0.0001 per share as of Q4 2023.
OnKure Therapeutics, Inc. - Common Stock, par value $0.0001 per share (RPHM) has 1 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 25,315 shares
of 12,657,935 outstanding shares and own 0.2% of the company stock.
Largest 10 shareholders include NEA Management Company, LLC (4,785,494 shares), TANG CAPITAL MANAGEMENT LLC (3,330,000 shares), Carlyle Group Inc. (2,698,957 shares), RiverVest Venture Management LLC (2,534,220 shares), Octagon Capital Advisors LP (2,250,000 shares), BML Capital Management, LLC (1,314,229 shares), HIGHBRIDGE CAPITAL MANAGEMENT LLC (1,121,704 shares), BlackRock Inc. (983,304 shares), VANGUARD GROUP INC (978,889 shares), and Aisling Capital Management LP (886,075 shares).
This table shows the top 1 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.